Corient Private Wealth LP Acquires Shares of 23,715 Teleflex Incorporated $TFX

Key Points

• Corient Private Wealth LP acquired 23,715 Teleflex shares worth approximately $3.0 million, while institutional investors and hedge funds collectively owned 95.62% of the company.
• Teleflex exceeded quarterly expectations, reporting $1.76 in EPS versus the $1.28 consensus and revenue of $570.33 million, up 28.9% year over year. The company issued fiscal 2026 EPS guidance of $6.90–$7.20.
• Analyst sentiment remains mixed, with an average “Hold” rating and $152.90 target price. Teleflex also announced a $0.34 quarterly dividend, equivalent to a 1.0% annualized yield.

Corient Private Wealth LP bought a new position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 23,715 shares of the medical technology company's stock, valued at approximately $3,006,000. Corient Private Wealth LP owned 0.06% of Teleflex at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. BlackRock Inc. acquired a new stake in Teleflex during the 2nd quarter valued at $688,537,000. Jupiter Topco LLC acquired a new position in shares of Teleflex in the second quarter valued at $550,456,000. Janus Henderson Group PLC raised its position in shares of Teleflex by 1.1% in the first quarter. Janus Henderson Group PLC now owns 4,291,311 shares of the medical technology company's stock valued at $513,281,000 after purchasing an additional 45,199 shares during the period. AQR Capital Management LLC lifted its stake in shares of Teleflex by 478.1% during the 3rd quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company's stock worth $287,603,000 after buying an additional 1,956,811 shares during the last quarter. Finally, State Street Corp lifted its stake in shares of Teleflex by 1.5% during the 4th quarter. State Street Corp now owns 1,478,776 shares of the medical technology company's stock worth $180,470,000 after buying an additional 22,111 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Stock Performance

NYSE TFX opened at $140.59 on Wednesday. The company has a quick ratio of 2.12, a current ratio of 2.60 and a debt-to-equity ratio of 0.94. The company has a market capitalization of $5.96 billion, a P/E ratio of -6.04, a P/E/G ratio of 0.95 and a beta of 0.82. Teleflex Incorporated has a 12-month low of $100.18 and a 12-month high of $145.00. The firm has a 50-day moving average price of $134.59 and a two-hundred day moving average price of $126.54.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.28 by $0.48. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The firm had revenue of $570.33 million for the quarter, compared to analyst estimates of $559.59 million. During the same quarter in the prior year, the business posted $3.73 EPS. The business's revenue was up 28.9% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Analysts anticipate that Teleflex Incorporated will post 7.26 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Friday, August 14th will be issued a $0.34 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.36 annualized dividend and a yield of 1.0%. Teleflex's payout ratio is currently -5.84%.

Analyst Ratings Changes

Several equities research analysts have issued reports on TFX shares. Raymond James Financial restated an "outperform" rating and set a $150.00 price objective on shares of Teleflex in a research report on Friday, May 8th. Needham & Company LLC upped their target price on Teleflex from $159.00 to $170.00 and gave the company a "buy" rating in a research report on Tuesday, August 25th. Royal Bank Of Canada upgraded Teleflex from a "sector perform" rating to an "outperform" rating and increased their target price for the stock from $135.00 to $155.00 in a research note on Friday, May 8th. Wall Street Zen upgraded Teleflex from a "sell" rating to a "hold" rating in a research note on Sunday, August 9th. Finally, Piper Sandler reaffirmed an "overweight" rating and issued a $169.00 price objective (up from $160.00) on shares of Teleflex in a report on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Teleflex presently has an average rating of "Hold" and an average target price of $152.90.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source